|
Originally published In Press as doi:10.1074/jbc.M202578200 on August 27, 2002
J. Biol. Chem., Vol. 277, Issue 44, 41736-41743, November 1, 2002
General Regulatory Factors (GRFs) as Genome Partitioners*
Geneviève
Fourel §,
Tsuyoshi
Miyake¶,
Pierre-Antoine
Defossez§,
Rong
Li¶, and
Éric
Gilson§
From the § CNRS/ENSL 5665, Ecole Normale
Supérieure de Lyon, 46 Allée d'Italie, F-69364 Lyon,
France and the ¶ Department of Biochemistry and Molecular
Genetics, University of Virginia, Charlottesville, Virginia 22908
Received for publication, March 18, 2002, and in revised form, August 22, 2002
 |
ABSTRACT |
Insulators are sequences that uncouple adjacent
chromosome domains. Here we have shown that Saccharomyces
cerevisiae Rap1p and Abf1p proteins are endowed with a potent
insulating capacity. Insulating domains in Rap1p coincide with
previously described transcription activation domains, whereas four
adjacent subdomains spanning the whole of the Abf1p C terminus
(440-731) were found to display autonomous insulating capacity. That
both Rap1p and Abf1p silencing domains either contain or largely
overlap with an insulating domain suggests that insulation conveys some
undefined chromosome organization capacity that also contributes a
function in silencing. Together with Reb1p and Tbf1p, previously
involved in the activity of Saccharomyces cerevisiae
subtelomeric insulators, insulating potential emerges as a
supplementary common property of General Regulatory Factors (GRFs).
Thus GRFs, which bind to sites scattered throughout the genome
within promoters, would not only play a key role in regulating gene
expression but also partition the genome in functionally independent domains.
 |
INTRODUCTION |
Abf1p, Reb1p, and Rap1p are three yeast transcription factors
known as General Regulatory Factors, or
GRFs.1 They share a number of
characteristics. First, they are abundant and essential. Second, one or
several binding sites for at least one of these factors are found in a
very large number of promoters. Third, these proteins behave as
obligate synergizers: their binding motifs usually have little
intrinsic regulatory activity but instead amplify the effect of
neighboring regulatory sites. They can enhance both activation or
repression of transcription. These properties were recognized in early
studies (1), then reconfirmed by more recent, systematic analysis (2,
3). Fourth, they are highly multifunctional proteins. Of the three
known DNA motifs that are part of silencers in Saccharomyces
cerevisiae, two are binding sites for GRFs (Rap1p and Abf1p), and
the third binds the ORC replication complex (4). Reb1p
critically assists polI transcription at the rDNA and further plays a
central role at silencers of another budding yeast, Kluyveromyces
lactis.2 In addition,
Rap1 and Abf1 can both regulate DNA replication initiation.
Finally, Abf1p was recently shown to play a role in nucleotide excision
repair (5).
Besides having comparable effects, the three GRFs seem to share a
common mechanism of action. Indeed, the binding site for one GRF within
a promoter can be exchanged with another, and even more compellingly,
protein domains can be swapped among GRFs without loss of function (6,
7). It has been hypothesized that GRF binding causes a local opening of
chromatin, which then permits increased binding of other transcription
factors (1, 8, 9). This idea is further substantiated by the fact that
the SWI/SNF chromatin remodeling complex appears to compensate for the
effect of deleting a Reb1p site in the GAL1 promoter or an Abf1p site in ARS1, on transcription and replication initiation, respectively (10, 11). Although distortions of DNA known to be
induced by GRFs at their binding sites may conceivably be involved, the
existence of mechanisms independent of their DNA-binding properties per se was inferred from the observation that activities of
GRFs can be transferred to some extent to heterologous DNA-binding domains. Rap1p and Abf1p were recently shown to be involved in the targeting of the NuA4 histone acetylase complex and of the TFIID
complex itself involved in the recruitment of the RNA polymerase II
machinery (12, 13). However, this concerns only a small subset of
promoters, which points to an additional determinant of specificity
(14, 15). Overall, the mechanism of action of GRFs is poorly understood
at present but is probably very indirect.
It is now well established that the genomes of higher eukaryotes are
organized into chromosomal domains that are independently regulated
(16). At the boundaries between domains have been found insulators, DNA
sequences that prevent the influence of enhancers and silencers from
spreading into adjacent regions, and therefore uncouple adjacent
domains (17). The genome of S. cerevisiae was
originally thought to be free of long-range regulations and of proper
chromosomal domains. However, studies culminating in the computational
analysis of whole genome expression data have revealed stretches of
co-regulated genes (18). In parallel, we and others have identified
chromatin insulators in this organism and in two instances GRFs were
implicated. We showed that Reb1p is involved in the insulator activity
of S. cerevisiae subtelomeric sequences called STARs, for
Subtelomeric Antisilencing Regions (19, 20). Reb1p shares this role
with Tbf1p, a DNA-binding protein the few known properties of which are
compatible with a GRF-like function (21, 22). The Upstream Activating
Sequence of the ribosome protein genes TEF (UASrpg) is another recently discovered yeast insulator. Its active core consists of three Rap1p
binding sites (23). We therefore decided to address whether the
capacity to organize a chromatin insulator is a general property of
GRFs. Rap1p and Abf1p were indeed found to contain insulator protein
domains, suggesting that GRFs are involved in boundary effects
throughout the yeast genome.
 |
EXPERIMENTAL PROCEDURES |
Yeast Strains--
Yeast strains described in this study are
derivatives of W303-1a and were obtained following standard genetic
manipulations as described in Ref. 20. The variegated expression of
URA3 and TRP1 was monitored as described in
detail in Ref. 19 by assessing the ratio of colonies growing on a
medium selecting for the repression of URA3 and/or the
expression of TRP1 versus the total number of
colonies growing on a non-selective medium. To correct for the
variability inherent to silencing assays, 6 to 12 cultures seeded with
independent colonies were assayed in parallel for any given strain.
Plasmids--
The Gal4-Rap1 chimeras harbor Gal4p region 1-94
tagged at its N terminus with a hemagglutinin (HA) epitope and are
expressed from the CUP1 promoter of constructs stably
integrated at the LEU2 chromosomal locus in the presence of
100 µM CuSO4. Portions of the RAP1 open
reading frame were obtained by PCR amplification of genomic DNA using
the HiFi expand system (Roche Molecular Biochemicals). Constructs were sequenced, and expression of the Gal4p chimeras was
checked by immunoblotting using an anti-HA antibody coupled with
peroxidase (Roche Molecular Biochemicals). Strains expressing roughly similar levels of fusion proteins were selected, and at least
two independent transformants derived from distinct plasmid clones were
then analyzed for each construct in silencing/insulation assays.
CEN-ARS pRS315- and pRS313-derived plasmids used to express Gal4-Abf1p
chimeras are described in Ref. 24. Although some chimeras contain Gal4
residues 1-147 and their expression is driven by the native
RAP1 promoter (pSB362 vector), and others carry Gal4 1-94
and are expressed from the ADH1 promoter (pYCAL vector), parallel experiments with some chimeras obtained in both systems as
well as in the pCUP system showed that these can be used
indiscriminately. Indeed, protein expression levels (24) and
results obtained with reporters of insulation were similar. The
construct used in end replacement at telomere VII-L to generate strain
GF101 was obtained as follows. A BglII-BamHI
fragment spanning four LexA sites was obtained by PCR using plasmid
psh1834 and inserted at the BglII site of pUASURTEL
(19). A BglII fragment containing the TRP1
gene and derived from pFL39 was then inserted at the reconstituted
BglII site. The LexA-Gal11 chimera was constructed in the
pEG202 vector and contained Gal11 residues 799-1081.
 |
RESULTS |
A Silencing Discontinuity Assay for Insulating Factors--
We
previously devised a Gal4-based tethering assay to identify proteins
that recapitulate insulator properties in S. cerevisiae (20). Strain GF100 carries four tandem binding sites for the transcription factor Gal4p (4xUASg) placed between two reporter genes,
URA3 and TRP1, at a fragmented VII-L telomere
(Fig. 1A). A STAR
derived from a subtelomeric Y' element (Y'-STAR) was interposed between TRP1 and the telomere. URA3 OFF colonies
are detected by virtue of their growth on medium containing
5-fluoro-orotic acid (FOA). We sensitized the assay by deleting
RIF1, which increases telomeric silencing. TRP1
is predominantly repressed because only 0.7% of the colonies grew on
medium lacking tryptophan (Fig. 1A, line 1,
SC-W). The fraction of URA3 OFF colonies was as
high as 70%, even though the reporter is 1.5 kb away from the telomere (Fig. 1A, line 2). Therefore it appears that
TRP1 and URA3 are only marginally protected from
the high level of silencing by the intervening STAR. Not a single
colony from GF100 rif1 cultures grew on SC-W+FOA of 5 × 106 cells, showing that in the few colonies where
TRP1 is ON, URA3 is also expressed. The 4xUASg
sequence, and the Gal4p DNA-binding domain peptide (GBD), have no
apparent effect on silencing by themselves (20) (Fig. 1, lines
1-3).


View larger version (88K):
[in this window]
[in a new window]
|
Fig. 1.
Delimitation of insulating domains in
Rap1p. The construct introduced by telomere fragmentation at
telomere VII-L in the GF100 reporter strain is shown at the bottom of
panels A and C. GF100 as used in panel
A was further modified by deleting the RIF1 open
reading frame, which boosts telomeric silencing. The parental GF100
strain was used in panel C to assay chimeras displaying
silencing capacity. Arrows indicate the 5'- to 3'-direction
of transcription of reporter genes. The Y'-STAR from telomere XII-L in
reverse orientation is represented as a stippled box and
four high affinity binding sites for the transcription factor Gal4p as
ovals (4xUASg). Tandem arrowheads represent
telomere repeats. The chimeras are represented on the left,
with the Gal4p DNA-binding domain as a black box. Rap1p
portions fused to the Gal4p DBD are shown aligned with the full-length
Rap1p protein. Rap1p has 827 amino acids and can be subdivided into
three regions: a central DNA binding domain (DBD) with two
Myb repeats and flanking domains of approximately equal size that have
been shown to display some functional redundancy (50, 51). The C
terminus of Rap1p contains regions involved in transcriptional
activation and stimulation of meiotic recombination (black
box) (26, 51), mating-type and telomeric silencing (stippled
box) (26, 52), and telomere length control (amino acids 726-827).
The N terminus of Rap1p contains a BRCT motif characterized by
conserved patches of hydrophobic residues, which can activate
transcription and remodel chromatin (25). Cultures were serially
diluted and grown on distinct medium: synthetic complete
(SC); SC+5-FOA, which only allows growth of cells that do
not express URA3; SC-W cells that express TRP1;
and SC-W+5-FOA cells that display both URA3 OFF and TRP1 ON,
i.e. cells in which TRP1 is insulated from the
silencing environment. Each diamond indicates the
ratio of colonies growing on a given medium versus SC for
single culture. The histogram bar represents the average of
the values obtained for expression of a given chimera. When not a
single colony grew out on selective medium from 10 µl of undiluted
culture, the ratio was estimated <2.10 5. B,
interpretative scheme. Silent chromatin is represented as a gradient to
indicate that silencing decreases with increasing distance from the
telomere. Insulators delimit a domain largely protected from silencing
while allowing efficient propagation of silent chromatin beyond this
domain. D, HA-tagged Gal4p fusion proteins were detected by
immunoblotting using an anti-HA monoclonal antibody. Equal amounts of
yeast extract were loaded, as verified by Ponceau staining. Two
independent yeast transformants were analyzed for the expression of
each construct, as indicated above two consecutive lanes.
GBD, Gal4p DNA-binding domain; ScR, S. cerevisiae Rap1, with the residue coordinates indicated
afterward; HuR, human Rap1; Abf1, residue
604-731 moiety from Abf1p. Yeasts harbored either a wild-type (+) or a
deleted copy ( ) of the HDF1 gene as indicated
below the panel. Shown is a composite of different gels
processed in parallel. The extrapolated position of molecular weight
markers is indicated on the left (in kilodaltons). Aberrant
migration was noted for three of the chimeras: the GBD-ScR1:361 and
GBD-Abf1 chimeras migrate at a higher position than expected, and the
GBD-ScR121:208 at a lower position. For some of the constructs, the two
analyzed strains expressed slightly different levels of the GBD
chimera, less than 3-fold as assessed independently. The GBD-ScR563:695
and 630:695 chimeras were expressed at a lower level than the average
(2- 3-fold), presumably because of the presence of a toxic domain. The
GBD-ScR1:361 chimera was generally found expressed at higher levels
than the average (3-fold), as shown here. However, clones that
expressed more average levels gave an identical silencing/insulation
pattern as that shown in panel A, lines
4-6.
|
|
A GBD chimera endowed with insulating capacities is expected to
recapitulate insulator properties in (i) improving TRP1
expression, by creating an insulated, silencing-free domain together
with the Y'-STAR, and (ii) allowing the growth of colonies on SC-W+FOA through the uncoupling of URA3 and TRP1, leaving
URA3 silencing essentially unaffected. This is illustrated
in Fig. 1B. We have previously shown (20) that GBD chimeras
containing Tbf1p or Reb1p moieties, as well as some transcription
activation domains from higher eukaryotes, fulfill these criteria.
Therefore, we first tested whether the transactivation domains found in
Rap1 and Abf1 also behave as insulators.
Insulating Domains in Rap1p Coincide with Transcription Activation
Domains--
Two transactivation domains were previously described in
Rap1p. The first is an 87-amino acid region with a BRCT motif found in
the first one-third of the protein. The second is 65 amino acids long
and resides in the last third of the protein (see Fig. 1A).
Chimeras carrying either the N-terminal third of the protein or
only the BRCT motif were expressed in strain GF100 rif1.
This slightly increased the fraction of TRP1 ON cells (Fig.
1A, lines 4 and 7) but did not affect
URA3 silencing (Fig. 1A, lines 5 and 8). Importantly, about 10% of the TRP1 ON cells
were now able to grow in the presence of FOA (Fig. 1A,
lines 6 and 9). The BRCT region of Rap1p
therefore complies with the definition of insulating domains. Mutation
of residues 206-208 of Rap1p into alanines, which abolishes the
transactivating potential of the BRCT domain (25), also abolished
its insulating capacity (data not shown).
Expression of chimeras containing the C-terminal activation domain
(amino acids 630-695), or a longer version extending into the
DNA-binding domain (amino acids 563-695) also allowed the growth of
colonies on SC-W+5-FOA medium (Fig. 1A, lines 12 and 15). However, this not only caused full
TRP1 derepression but also a large decrease of
URA3 silencing (Fig. 1A, lines 11 and 14). We could not ascertain whether this is because of
strong protection against silencing, as previously shown for potent
insulators (20), or because of direct transactivation of the
TRP1 and/or URA3 promoters by the chimera.
Close reexamination of the initial studies that delimitated the
C-terminal transcription activation domain indicated that while region
630-695 corresponds to the minimal domain endowed with transcription
activation potential, extending it up to position 727 significantly
augments its activity (26). Moreover, a domain located C-terminal to
position 653 also possesses autonomous transcription activation
potential, as revealed upon truncation of the Rap1p C terminus (27).
Strikingly, regions 630-727 and 653-727 clearly behaved as insulators
(Fig. 1A, lines 16-21). They increased the proportion of TRP1 ON colonies (going up to almost 100% for
630-727; line 16), did not modify URA3 silencing
(lines 17 and 20), and accordingly allowed a
large fraction of the colonies to grow on SC-W+FOA medium (lines
18 and 21).
The chimera containing Rap1 region C-terminal to position 727 had no
distinguishable effect (Fig. 1A, compare lines
1-3 and 22-24). The same was true for a shorter
chimera containing only the C-terminal region with high similarity to
human Rap1 (hRap1) (28) (Fig. 1A, lines 25-27)
or the corresponding region from the human peptide (data not shown).
We then addressed whether the insulating activity of the Rap1p
C-terminal activation domain could still be observed in the context of
a larger chimera containing an intact silencing domain. For this we
used a strain with a wild-type RIF1 gene. In this situation
both URA3 and TRP1 genes are predominantly
expressed (Fig. 1C, lines 1-2), and silencing
effects can be detected. When GBD alone was expressed a few colonies
grew on SC-W+5-FOA medium (Fig. 1C, line 3).
Expression of GBD chimeras carrying either the 563-827 or 653-827
Rap1p regions resulted in strong and coupled silencing of both
URA3 and TRP1 (Fig. 1C, lines
4-9). This presumably arose as a consequence of the potent,
bi-directional silencing relay activity of the domain targeted at the
4xUASg (29). The potent repressive effect of these chimeras therefore
surpasses their insulating potential.
Of note, all chimeric proteins were expressed at roughly similar levels
(Fig. 1D, see also "Experimental Procedures").
Furthermore, there appeared to be no correlation between slight
differences in relative expression levels and the amplitude of
associated silencing/insulation effects. For instance, the GBD-Rap1p
563-695 and 630-695 chimeras were expressed at lower levels than the
average but displayed strong anti-silencing and insulation effects.
Conversely, the GBD-Rap1p 727-827 and 784-827 chimeras, as well
as the human equivalent of the latter had no effect in either silencing
or insulation although expressed at average levels.
In summary, Rap1p protein harbors two insulating domains, one that
coincides with the BRCT motif (amino acids 121-208) and the other in
the C terminus corresponding to the previously characterized transactivation domain (amino acids 630-727). Subdomains of the latter
region (630-695 and 653-727) were also active. Interestingly, the
Rap1p silencing domain largely overlaps with the 653-727 insulating region, raising the intriguing possibility that the latter function contributes to silencing capacity.
Cooperating Insulating Domains in the C Terminus of
Abf1p--
Because the transcription activation domain of Abf1p
appears to coincide with the minimal silencing domain, we decided to perform dissection analysis of Abf1p in search of insulating domains in
the GF100 strain harboring a wild-type RIF1 gene. Chimeras not endowed with silencing capacity were assayed in parallel in GF100 rif1 (data not shown).
Abf1p region 604-731 somewhat repressed TRP1 and
URA3 expression (Fig.
2A, compare lines
1-2 and 4-5). It also exhibited significant uncoupling activity, because about 1% of the URA3 OFF
colonies were now TRP1 ON (Fig. 2A, line
6). Abf1p region 604-662 also displayed silencing and insulating
activities, both to a lesser extent than the longer 604-731 chimera.
This is consistent with the observation that region 663-731 has
insulating capacity (Fig. 2A, line 12 and
confirmed in GF100 rif1). Thus, Abf1p regions 604-662 and
663-731 cooperate both for silencing (as previously reported in Ref.
24) and for insulation. The Abf1p C-terminal region up to position 607, for which no activity had been described so far, is also endowed with
insulating potential (Fig. 2A, line 13-15 and
confirmed in GF100 rif1). Furthermore, the insulating activity of the full 440-731 C-terminal region essentially masked its
silencing capacity (Fig. 2A, line 16-18). This
stands in sharp contrast with the behavior of the Rap1 C terminus for
which, on the contrary, silencing activity predominated over insulation (see above).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 2.
Delimitation of insulating domains in
Abf1p. Dissection of the C terminus 440-731 region (A)
and refinement of the analysis for the 604-731 region (B)
with the use of mutants carrying alanine substitutions in regions that
are essential for viability in the context of the full-length protein
(A624-628 and A644-648). Abf1p portions fused to the Gal4p DNA
binding domain are shown in panel A aligned with the
full-length Abf1p protein; the 604-731 region is shown enlarged in
panel B. The DNA-binding domain of Abf1p is
contained in the first 500 amino acids (53). Region 604-662 apparently
harbors all the determinants responsible for activation of
transcription and replication and chromatin remodeling (black
box) (7, 24, 54, 55). It can be further shortened to amino acids
633-662 with only minimal loss in all three activities (24). Abf1p
region 604-662 additionally constitutes a minimal silencing domain
(stippled box), the function of which may be further aided
by additional sequences in 663-731 (gray motif) (24).
GBD-Abf1p chimeras were expressed in GF100 strain using two
different expression systems (see "Experimental Procedures").
Details are otherwise the same as in the Fig. 1 legend.
|
|
A detailed analysis recently showed that two short regions within the
604-662 multifunctional domain, 624-628 and 644-648, are essential
for cell viability (24). We found that the 644-648 mutation rendered
both 604-662 and 604-731 chimeras null for silencing (Fig.
2B, compare lines 4-5 and 10-11 and
lines 13-14 and 19-20). The mutation
also completely inactivated region 604-662 for insulation. In
contrast, it only had a moderate impact on insulation by the 604-731
chimera (Fig. 2B, lines 21 and 12).
This is probably due to the presence in this region of a second
insulation domain, within residues 662-731 (see above). In contrast,
mutation of amino acids 624-628 had little effect and actually
slightly improved the insulating ability of the 604-662 chimera (Fig.
2B, line 18).
A very short domain, between amino acids 633-662, has been shown to be
almost as active as full-length Abf1p in stimulating transcription and
replication (24). Strikingly this domain also displayed robust
silencing and insulator capacity (Fig. 2B, lines 25-27). The complementary 604-633 subdomain is devoid of
silencing activity and faintly uncouples URA3 and
TRP1 expression (Fig. 2B, lines 22-24
and confirmed in GF100 rif1). The different GBD-Abf1p fusion proteins were expressed at similar levels (24) that compare with
average expression levels of Rap1p fusions (Fig. 1D).
In conclusion, the transcription activation domain of Abf1p (amino
acids 633-662) is also an insulation domain, which parallels our
findings in Rap1p. However, adjacent subdomains of Abf1p devoid of
transactivating potential (440-604, 604-633, 662-731) can also insulate in a cooperative albeit partially redundant manner. The minimal silencing domain of Abf1p (604-662) is therefore also endowed
with insulating capacity, and an adjacent region (662-731) plays an
accessory role in silencing and cooperates in insulation.
Coupled Insulating and Silencing Capacities of the Rap1p C
Terminus--
The silencing domain of Abf1p (604-731) is also an
insulator. It was plausible that we had failed to detect a similar
activity in the silencing domain of Rap1p (655-827) simply because
Rap1p silencing activity is much stronger. In that case we reasoned that we might be able to uncover insulating capacity by modulating the
transcriptional activity of one of the reporter genes.
To address this possibility, we used strain GF101, in which
the order of URA3 and TRP1 is reversed relative
to GF100 (Fig. 3A). This
strain also has 4xLexA sites upstream of the TRP1 gene promoter so that expression of a LexA-Gal11 chimera, which recruits the
RNA polymerase II holoenzyme (30), permits transactivation of
TRP1. The control chimera consisting of the GBD alone was
expressed in a rif1 background to provide a control
setting of high silencing that would compare with that observed upon
targeting of silencing domains to the 4xUASg, which is indeed the case
as far as Abf1p is concerned (Fig. 3A, compare lines
1-2 and 7-8). Of note, expression of the LexA
DNA-binding domain alone had no influence on the silencing pattern of
this strain (data not shown).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
Coupled insulating and silencing capacities
of the Rap1p C terminus. A, the construct introduced by
telomere fragmentation at telomere VII-L in the GF101 reporter strain
is shown at the bottom. Binding sites for the bacterial LexA
protein and Gal4p are indicated as ovals. Each Gal4 chimera
was expressed using the pCUP system together with either LexA or
the LexA-Gal11p chimera, expressed from a plasmid selected through
histidine deprivation (see "Experimental Procedures"). Either the
parental GF101 strain or a rif1 derivative was used, as
mentioned below the schemes of Gal4 chimeras. Increase in the
background of colonies growing on SC-W+5-FOA medium is intrinsic to
this experiment (see panel A, line 6). Therefore
only the 0.1-100% range is represented to highlight specific effects.
B, interpretative scheme. Targeting of LexA to cognate
binding sites upstream of the TRP1 gene does not affect
silencing in subtelomeric regions subjected to the silencing relay
activity of Abf1p or Rap1p domains targeted to UASg motifs. Expression
of LexA-Gal11p induces targeted recruitment of the RNA polymerase II
machinery at the TRP1 promoter and relieves it from
silencing, presumably because of efficient competition of the
transcription process with establishment of silent chromatin. Silencing
is nevertheless not affected beyond Rap1p/Abf1p sites of targeting.
Details are otherwise the same as in the Figs. 1 and 2 legends.
|
|
As expected, expression of LexA-Gal11 led to a predominant expression
of TRP1, irrespective of the Gal4 chimera targeted to the
4xUASg (Fig. 3A, lines 5, 11,
17, 23). This also strongly impaired
URA3 silencing in the strain GF101 with the GBD alone but
not with the Abf1p 608-731 and Rap1p 563-827 or 653-827 silencing chimeras (Fig. 3A, compare lines 1 and
4, 7 and 10, 13 and
14, 19 and 22). Furthermore,
expression of the latter chimeras, but not of GBD alone, induced a
large fraction of cells to grow on SC-W+FOA (Fig. 3A,
lines 12, 18, 24). Thus, these
chimeras uncoupled the regulation of adjacent chromosomal domains,
allowing at the same time predominant silencing of URA3 and
expression of TRP1 (Fig. 3B).
 |
DISCUSSION |
GRFs as Genome Partitioners--
Chromosomal insulators were first
described in a variety of higher eukaryotes, and more recently in
yeast, as specialized sequences that allow adjacent chromosomal domains
to be independently regulated (17). In a growing number of cases,
promoters themselves were shown to act as insulators in a
transcription-independent manner (23, 31-33). One simple explanation
for this would be that some transcriptional regulators are endowed with
insulating capacity. The work reported here, together with our previous
observations (20), shows that it is indeed the case for Abf1p, Rap1p,
and Reb1p, three yeast transcription factors that share a number of distinctive features and are known as General Regulatory Factors. Abf1p
and Rap1p contain potent insulating domains, and although not
investigated here, DNA binding per se and the DNA-binding domains of Rap1p and Abf1p may further contribute to their insulating activity in the context of full-length proteins.
One prediction would thus be that promoters containing combinations of
binding sites for Rap1p, Abf1p, and Reb1p (as well as Tbf1p; Ref. 20)
should behave as insulators. This is in good accordance with the
available data; furthermore, a screen designed to recover yeast genomic
fragments that contain insulators has indeed retrieved many such
sequences.3 The documented
role of Abf1p and Reb1p in reducing transcriptional interference may be
reinterpreted in the light of these new findings (34). An important
consequence is that GRFs, which are abundant and bind to many promoters
across the genome, may not only play a key role in regulating gene
expression but may also partition chromosomes in functionally
independent domains. Classic transcription activators endowed with
insulating capacity (20) may also contribute to this partitioning
although acting at a more restricted number of UASs. This idea
reconciles the fact that, although essentially no transcription
regulatory sequences other than promoters were found in yeast, most
genes actually appear regulated independently despite short intergenic
regions (18).
Mechanism of Insulation by GRFs--
Chromatin modifications that
are known to occur at promoters and that are incompatible with
silencing may be envisaged to account for a barrier effect to
heterochromatin propagation. However, simply creating a nucleosomal gap
appears not sufficient for barrier activity (33). Furthermore, it is
more difficult to envision how such local modifications may allow for
discontinuous propagation of silencing (Refs. 19, 20, 35 and this
study) or induce an enhancer-blocking effect (31), suggesting a more
specific mechanism. The ability of GRFs to activate transcription,
control replication, and cause insulation seems to be interdependent, as indicated by the overlapping of the protein domains involved. Transcription and replication are compartmentalized processes within
the nucleus (36). This probably accounts for the fact that many
transcription and replication factors co-purify with a nuclear scaffold
fraction (37), as is notably the case for Rap1p and the ORC complex in
yeast (38, 39). We propose that GRFs act mainly by directing
genomic loci to nuclear subcompartments that are competent for specific
DNA transactions. This would explain why GRFs are not intrinsic
transactivators but cooperate with other promoter-bound proteins and
why deletion of a GRF-binding site cannot be compensated for by
artificially recruiting the Pol II machinery and/or destabilizing
chromatin by depletion of histone H4 (40).
Insulation might be another consequence of recruitment to these nuclear
subcompartments. Support for a correlation between insulator activity
and higher order nuclear organization also comes from studies in other
species such as Drosophila. Indeed, copies of the gypsy
insulator sequence inserted in distinct genomic locations appear to be
associated with particular nuclear substructure (41).
Silencers can be considered as insulators in the sense that they allow
decoupling in the regulation of adjacent chromosome domains, as shown
here and consistent with previous reports (32, 33). This effect may
result both from stabilization of silent chromatin over a domain and
from an `enhancer-blocking' type protection of promoters
vis-à-vis long-range activation of transcription initiation (42).
The fact that silencers as well as telomeres are strongly
anchored to a nuclear substructure in a SIR-independent manner (38, 43,
44), together with the fact that both Rap1p and Abf1p silencing domains
either contain or largely overlap with a minimal insulating domain,
strongly supports the idea that genome-organizing properties of GRFs
may be fundamentally involved in their silencing functions.
GRFs and Insulation in Higher Eukaryotes--
We would like to
speculate that the ideas originating from this work will be applicable
in multicellular eukaryotes. CTCF is the only known insulating protein
in vertebrates; it acts at many different loci, and it highly conserved
(Ref. 45 and references therein). Remarkably, CTCF displays
characteristic GRF features. In particular, it is able to synergize
with other factors in repression as well as in activation (45, 46) and
partitions with a nuclear scaffold
fraction.4 The GAGA factor in
Drosophila, known to bind to a very large number of
promoters, has been further implicated in the assembly of PcG
repressive complexes at polycomb response elements and in insulator
activities (31, 47), characteristics which strikingly parallel those of
Rap1p in yeast. Another GRF-like factor that emerges as a good
candidate for an insulating protein is YY-1 (48). Like CTCF, it is
highly conserved among human, mouse, and Xenopus and has
nuclear scaffold-associated partners. YY-1 was recently implicated in
the reiterated targeting of a repressive complex at D4Z4 repeats in
human, which results in the extinction of 4q35 genes through a
repression mechanism that displays many common features with
heterochromatin-mediated silencing (49). Whether YY-1 has insulating
capacity has not been reported as yet.
 |
ACKNOWLEDGEMENTS |
We thank S. Marcand and R. Morse for plasmid
gifts. We are grateful to D. Donze, R. Renkawitz, and S. U.
Aström, for sharing unpublished results and to Y. Pilpel for
enlightening discussions.
 |
FOOTNOTES |
*
This work was supported by La Ligue Nationale contre le
Cancer (to E. G.) and the National Institutes of Health (to R. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 33-472728162;
Fax: 33-472728686; E-mail: Genevieve.Fourel@ens-lyon.fr.
Published, JBC Papers in Press, August 27, 2002, DOI 10.1074/jbc.M202578200
2
S. U. Aström, personal communication.
3
D. Donze, personal communication.
4
R. Renkawitz, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
GRF, general
regulatory factor;
STAR, subtelomeric antisilencing region;
UAS, upstream activating sequence;
HA, hemagglutinin;
FOA, 5-fluoro-orotic
acid;
DBD, DNA binding domain;
GBD, Gal4p DNA binding domain;
ORC, origin recognition complex;
SIR, silent information
regulator.
 |
REFERENCES |
| 1.
|
Chasman, D. I.,
Lue, N. F.,
Buchman, A. R.,
Lapointe, J. W.,
Lorch, Y.,
and Kornberg, R. D.
(1990)
Genes Dev.
4,
503-514[Abstract/Free Full Text]
|
| 2.
|
Pilpel, Y.,
Sudarsanam, P.,
and Church, G. M.
(2001)
Nat. Genet.
29,
153-159[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Bussemaker, H. J., Li, H.,
and Siggia, E. D.
(2001)
Nat. Genet.
27,
167-171[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Gartenberg, M. R.
(2000)
Curr. Opin. Microbiol.
3,
132-137[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Reed, S. H.,
Akiyama, M.,
Stillman, B.,
and Friedberg, E. C.
(1999)
Genes Dev.
13,
3052-3058[Abstract/Free Full Text]
|
| 6.
|
Lieb, J. D.,
Liu, X.,
Botstein, D.,
and Brown, P. O.
(2001)
Nat. Genet.
28,
327-334[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Goncalves, P. M.,
Maurer, K.,
van Nieuw Amerongen, G.,
Bergkamp-Steffens, K.,
Mager, W. H.,
and Planta, R. J.
(1996)
Mol. Microbiol.
19,
535-543[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Hu, Y.-F.,
Hao, Z. L.,
and Li, R.
(1999)
Genes Dev.
13,
637-642[Abstract/Free Full Text]
|
| 9.
|
Yu, L.,
and Morse, R. H.
(1999)
Mol. Cell. Biol.
19,
5279-5288[Abstract/Free Full Text]
|
| 10.
|
Burns, L. G.,
and Peterson, C. L.
(1997)
Mol. Cell. Biol.
17,
4811-4819[Abstract]
|
| 11.
|
Flanagan, J. F.,
and Peterson, C. L.
(1999)
Nucleic Acids Res.
27,
2022-2028[Abstract/Free Full Text]
|
| 12.
|
Reid, J. L.,
Iyer, V. R.,
Brown, P. O.,
and Struhl, K.
(2000)
Mol. Cell
6,
1297-1307[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Mencia, M.,
Moqtaderi, Z.,
Geisberg, J. V.,
Kuras, L.,
and Struhl, K.
(2002)
Mol. Cell
9,
823-833[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Deminoff, S. J.,
and Santangelo, G. M.
(2001)
Genetics
158,
133-143[Abstract/Free Full Text]
|
| 15.
|
Idrissi, F. Z.,
Garcia-Reyero, N.,
Fernandez-Larrea, J. B.,
and Pina, B.
(2001)
J. Biol. Chem.
276,
26090-26098[Abstract/Free Full Text]
|
| 16.
|
Lercher, M. J.,
Urrutia, A. O.,
and Hurst, L. D.
(2002)
Nat. Genet.
31,
180-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Sun, F.-L.,
and Elgin, S. C. R.
(1999)
Cell
99,
459-462[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Cohen, B. A.,
Mitra, R. D.,
Hughes, J. D.,
and Church, G. M.
(2000)
Nat. Genet.
26,
183-186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Fourel, G.,
Revardel, E.,
Koering, C. E.,
and Gilson, E.
(1999)
EMBO J.
18,
2522-2537[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Fourel, G.,
Boscheron, C.,
Revardel, E.,
Lebrun, E., Hu, Y.-F.,
Carmine Simmen, K.,
Müller, K., Li, R.,
Mermod, N.,
and Gilson, E.
(2001)
EMBO Rep.
2,
124-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Koering, C. E.,
Fourel, G.,
Klein, F.,
Binet-Brasselet, E.,
Laroche, T.,
Gasser, S.,
and Gilson, E.
(2000)
Nucleic Acids Res.
28,
2519-2526[Abstract/Free Full Text]
|
| 22.
|
Gavin, A. C.,
Bosche, M.,
Krause, R.,
et al..
(2002)
Nature
415,
141-147[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Bi, X.,
and Broach, J. R.
(1999)
Genes Dev.
13,
1089-1101[Abstract/Free Full Text]
|
| 24.
|
Miyake, T.,
Loch, C. M.,
and Li, R.
(2002)
Mol. Cell. Biol.
22,
505-516[Abstract/Free Full Text]
|
| 25.
|
Miyake, T., Hu, Y.-F., Yu, D. S.,
and Li, R.
(2000)
J. Biol. Chem.
275,
40169-40173[Abstract/Free Full Text]
|
| 26.
|
Hardy, C. F.,
Balderes, D.,
and Shore, D.
(1992)
Mol. Cell. Biol.
12,
1209-1217[Abstract/Free Full Text]
|
| 27.
|
Moretti, P.,
Freeman, K.,
Coodly, L.,
and Shore, D.
(1994)
Genes Dev.
8,
2257-2269[Abstract/Free Full Text]
|
| 28.
|
Li, B.,
Oestreich, S.,
and de Lange, T.
(2000)
Cell
101,
471-483[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Lebrun, E.,
Revardel, E.,
Boscheron, C., Li, R.,
Gilson, E.,
and Fourel, G.
(2001)
Genetics
158,
167-176[Abstract/Free Full Text]
|
| 30.
|
Keaveney, M.,
and Struhl, K.
(1998)
Mol. Cell
1,
917-924[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Ohtsuki, S.,
and Levine, M.
(1998)
Genes Dev.
12,
3325-3330[Abstract/Free Full Text]
|
| 32.
|
Sekinger, E. A.,
and Gross, D. S.
(1999)
EMBO J.
18,
7041-7055[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Donze, D.,
and Kamakaka, R. T.
(2001)
EMBO J.
20,
520-531[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Valerius, O.,
Brendel, C.,
Düvel, K.,
and Braus, G. H.
(2002)
J. Biol. Chem.
277,
21440-21445[Abstract/Free Full Text]
|
| 35.
|
Pryde, F. E.,
and Louis, E. J.
(1999)
EMBO J.
18,
2538-2550[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Berezney, R.,
and Wei, X.
(1998)
J. Cell. Biochem.
31 (suppl.),
238-242
|
| 37.
| Stenoien, D. L., Simeoni, S., Sharp, Z. D., and Mancini, M. A. (2000) J. Cell. Biochem. (Suppl.) 99-106
|
| 38.
|
Hoffmann, J. F. X.,
Laroche, T.,
Brand, A. H.,
and Gasser, S. M.
(1989)
Cell
57,
725-737[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Amati, B. B.,
and Gasser, S. M.
(1988)
Cell
54,
967-978[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Ryan, M. P.,
Stafford, G. A., Yu, L.,
and Morse, R. H.
(2000)
Mol. Cell. Biol.
20,
5847-5857[Abstract/Free Full Text]
|
| 41.
|
Gerasimova, T. I.,
Byrd, K.,
and Corces, V. G.
(2000)
Mol. Cell
6,
1025-1035[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
de Bruin, D.,
Zaman, Z.,
Liberatore, R. A.,
and Ptashne, M.
(2001)
Nature
409,
109-113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Mirabella, A.,
and Gartenberg, M.
(1997)
EMBO J.
16,
523-533[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Heun, P.,
Laroche, T.,
Shimada, K.,
Furrer, P.,
and Gasser, S. M.
(2001)
Science
294,
2181-2186[Abstract/Free Full Text]
|
| 45.
|
Ohlsson, R.,
Renkawitz, R.,
and Lobanenkov, V.
(2001)
Trends Genet.
17,
520-527[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Lutz, M.,
Baniahmad, A.,
and Renkawitz, R.
(2000)
Biochem. Soc. Trans.
28,
386-389[Medline]
[Order article via Infotrieve]
|
| 47.
|
Horard, B.,
Tatout, C.,
Poux, S.,
and Pirrota, V.
(2000)
Mol. Cell. Biol.
20,
3187-3197[Abstract/Free Full Text]
|
| 48.
|
Thomas, M. J.,
and Seto, E.
(1999)
Gene
236,
197-208[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Gabellini, D.,
Green, M. R.,
and Tupler, R.
(2002)
Cell
110,
339-348[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Graham, I. R.,
Haw, R. A.,
Spink, K. G.,
Halden, K. A.,
and Chambers, A.
(1999)
Mol. Cell. Biol.
19,
7481-7490[Abstract/Free Full Text]
|
| 51.
|
Kirkpatrick, D. T.,
Fan, Q.,
and Petes, T. D.
(1999)
Genetics
152,
101-115[Abstract/Free Full Text]
|
| 52.
|
Buck, S. W.,
and Shore, D.
(1995)
Genes Dev.
9,
370-384[Abstract/Free Full Text]
|
| 53.
|
Cho, G.,
Kim, J.,
Rho, H. M.,
and Jung, G.
(1995)
Nucleic Acids Res.
23,
2980-2987[Abstract/Free Full Text]
|
| 54.
|
Li, R., Yu, D. S.,
Tanaka, M.,
Zheng, L.,
Berger, S. L.,
and Stillman, B.
(1998)
Mol. Cell. Biol.
18,
1296-1302[Abstract/Free Full Text]
|
| 55.
|
Wiltshire, S.,
Raychaudhuri, S.,
and Eisenberg, S.
(1997)
Nucleic Acids Res.
25,
4250-4256[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. J. Venters and B. F. Pugh
A canonical promoter organization of the transcription machinery and its regulators in the Saccharomyces genome
Genome Res.,
March 1, 2009;
19(3):
360 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yu, J. B. Smirnova, E. C. Friedberg, B. Stillman, M. Akiyama, T. Owen-Hughes, R. Waters, and S. H. Reed
ABF1-binding Sites Promote Efficient Global Genome Nucleotide Excision Repair
J. Biol. Chem.,
January 9, 2009;
284(2):
966 - 973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Rehman, D. Wang, G. Fourel, E. Gilson, and K. Yankulov
Subtelomeric ACS-containing Proto-silencers Act as Antisilencers in Replication Factors Mutants in Saccharomyces cerevisiae
Mol. Biol. Cell,
January 1, 2009;
20(2):
631 - 641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bendjennat and P. A. Weil
The Transcriptional Repressor Activator Protein Rap1p Is a Direct Regulator of TATA-binding Protein
J. Biol. Chem.,
March 28, 2008;
283(13):
8699 - 8710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Garbett, M. K. Tripathi, B. Cencki, J. H. Layer, and P. A. Weil
Yeast TFIID Serves as a Coactivator for Rap1p by Direct Protein-Protein Interaction
Mol. Cell. Biol.,
January 1, 2007;
27(1):
297 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Kuehner and D. A. Brow
Quantitative Analysis of in Vivo Initiator Selection by Yeast RNA Polymerase II Supports a Scanning Model
J. Biol. Chem.,
May 19, 2006;
281(20):
14119 - 14128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, D. O. Richardson, D. N. Roberts, R. Utley, H. Erdjument-Bromage, P. Tempst, J. Cote, and B. R. Cairns
The Yaf9 Component of the SWR1 and NuA4 Complexes Is Required for Proper Gene Expression, Histone H4 Acetylation, and Htz1 Replacement near Telomeres
Mol. Cell. Biol.,
November 1, 2004;
24(21):
9424 - 9436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yarragudi, T. Miyake, R. Li, and R. H. Morse
Comparison of ABF1 and RAP1 in Chromatin Opening and Transactivator Potentiation in the Budding Yeast Saccharomyces cerevisiae
Mol. Cell. Biol.,
October 15, 2004;
24(20):
9152 - 9164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oki, L. Valenzuela, T. Chiba, T. Ito, and R. T. Kamakaka
Barrier Proteins Remodel and Modify Chromatin To Restrict Silenced Domains
Mol. Cell. Biol.,
March 1, 2004;
24(5):
1956 - 1967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Van Slyke and E. J. Grayhack
The essential transcription factor Reb1p interacts with the CLB2 UAS outside of the G2/M control region
Nucleic Acids Res.,
August 1, 2003;
31(15):
4597 - 4607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yu, R. Qiu, T. B. Foland, D. Griesen, C. S. Galloway, Y.-H. Chiu, J. Sandmeier, J. R. Broach, and X. Bi
Rap1p and other transcriptional regulators can function in defining distinct domains of gene expression
Nucleic Acids Res.,
February 15, 2003;
31(4):
1224 - 1233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-A. Defossez and E. Gilson
The vertebrate protein CTCF functions as an insulator in Saccharomyces cerevisiae
Nucleic Acids Res.,
December 1, 2002;
30(23):
5136 - 5141.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|